logo

For the Inventor, By the Inventor

Rescaldina, Italy

Annibale Gazzaniga

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent. Top assignees: Zambon Group, Zambon S.p.a.. Active years: 1987-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annibale Gazzaniga. Retrieved from https://idiyas.com/inventor/annibale-gazzaniga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 100.0


Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 194(Granted Patents)


Location History:

  • Milan, IT (1997)
  • Rescaldina, IT (1987 - 1998)

Company Filing History:

goldMedal12 out of 138 
 
Zambon Group
 patents
silverMedal2 out of 79 
 
Zambon S.p.a.
 patents

Years Active: 1987-1998

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 5807894 - Syrup containing N-acetyl-cysteine (1998-09-15),
2. 5693312 - Pharmaceutical composition having analgesic activity (1997-12-02),
3. 5645857 - Pharmaceutical composition having analgesic activity (1997-07-08),
4. 5519054 - Pharmaceutical compositions containing N-acetyl-cysteine derivatives (1996-05-21),
5. 5510385 - Pharmaceutical compositions containing the salts of (1996-04-23),
6. 5510101 - Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and (1996-04-23),
7. 5500226 - Pharmaceutical composition having analgesic activity (1996-03-19),
8. 5488069 - Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and (1996-01-30),
9. 5463117 - Process for the preparation of salts of 2-(4-isobutylphenyl)propionic (1995-10-31),
10. 5459157 - Pharmaceutical composition for ophthalmic use comprising a nonsteroidal (1995-10-17),
11. 5312627 - Transdermal therapeutic system for the administration of drugs having (1994-05-17),
12. 5227404 - Pharmaceutical composition for the treatment of glaucomatous optic (1993-07-13),
13. 4834966 - Pharmaceutical composition with analgesic activity (1989-05-30),
14. 4689218 - Effervescent composition with analgesic activity (1987-08-25),

Title: Inventor Spotlight: Annibale Gazzaniga

Introduction

Annibale Gazzaniga, a prominent inventor based in Rescaldina, Italy, has made significant contributions to the field of pharmaceuticals. With a robust portfolio of 14 patents, Gazzaniga's innovations reflect his commitment to enhancing health outcomes.

Latest Patents

Among his latest inventions are two noteworthy patents. The first is a syrup containing N-acetyl-cysteine, designed to be stable for at least two years. This syrup features a pleasant taste and smell and consists of an aqueous solution of NAC, a sweetening agent, and a thickening agent. Additionally, it may contain a flavoring agent and a preservative, with a pH level maintained between 5 and 8. The second patent involves a pharmaceutical composition that possesses analgesic activity. This composition incorporates (S)-2-(6-methoxy-2-naphthyl)-propionic acid as an active ingredient, combined with arginine, thus facilitating the development of effective oral pharmaceutical forms.

Career Highlights

Gazzaniga's career has been marked by his work with reputable companies. He has been associated with the Zambon Group S.p.A. and Zambon S.p.A., where he has played a pivotal role in advancing pharmaceutical innovations. His dedication and expertise have allowed him to navigate complex projects and enhance product offerings in the marketplace.

Collaborations

Throughout his career, Gazzaniga has collaborated with a team of talented professionals. Notable coworkers include Federico Stroppolo and Daniele Bonadeo, with whom he has shared insights and knowledge, contributing to fruitful innovations in the field.

Conclusion

Annibale Gazzaniga's contributions to the pharmaceutical industry through his inventive spirit and partnership with esteemed companies illustrate the value of innovation in improving health solutions. His latest patents are a testament to his expertise and commitment to advancing health-related products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…